Musculoskeletal Impairment in Headaches Attributed to Rhinosinusitis

September 17, 2020 updated by: Des Moines University

Musculoskeletal Neck Impairment in Headaches Attributed to Rhinosinusitis

Neck pain, neck muscle weakness, and limited neck range of motion have been shown in individuals with sinus headaches. Individuals in this previous study self-diagnosed their sinus headaches. It is unknown whether or not individuals who have been diagnosed with sinus headaches according to diagnostic criteria also present with musculoskeletal impairments.

The purpose of this study is to determine if musculoskeletal neck impairments are present in individuals diagnosed with headaches attributed to rhinosinusitis compared to people without headaches.

Upper cervical range of motion can be measured using different tests. The side bend rotation test has been suggested as potentially more useful than the flexion rotation test in individuals with hyper-laxity, however, has not been examined in a symptomatic population.

A secondary purpose is to compare the side bend rotation test to the cervical flexion rotation test in people with varying degrees of joint laxity.

Study Overview

Detailed Description

Design: Observational, case control Background: A recent study showed neck pain, neck muscle weakness, and limited neck range of motion in individuals who reported having sinus headaches. These impairments are also associated with cervicogenic headaches (headaches originating in the neck), but had not previously been shown in people with sinus headaches.

Because the individuals in this previous study self-diagnosed their sinus headaches, it is possible that they did not have sinus headaches but rather had a different kind of headache. It is unknown whether or not individuals who have been diagnosed with sinus headaches according to diagnostic criteria also present with musculoskeletal impairments.

Purpose 1: The purpose of this study is to determine if musculoskeletal neck impairments are present in individuals diagnosed with headaches attributed to rhinosinusitis (sinus headaches) compared to people without headaches. Question: Do people with diagnosed with headaches attributed to rhinosinusitis have neck pain or impairments in neck strength, neck range of motion, or segmental neck joint mobility compared to people without headaches?

Background for question 2: Upper cervical range of motion can be measured using the flexion-rotation test or the side bend rotation test. The side bend rotation test has been suggested as potentially more useful in individuals with hyper-laxity, however, has not been examined in a symptomatic population.

Purpose 2: To compare the side bend rotation test to the cervical flexion rotation test and manual joint assessment in people with varying degrees of joint laxity. Question: What is the diagnostic accuracy of the side bend rotation test compared to the index tests of the flexion rotation test and manual joint assessment?

Study Type

Observational

Enrollment (Anticipated)

82

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Connecticut
      • Hartford, Connecticut, United States, 06117
        • Recruiting
        • University of Hartford
        • Contact:
          • Brian Swanson
          • Phone Number: 860-768-5314
    • Iowa
      • Des Moines, Iowa, United States, 50325
        • Recruiting
        • Des Moines University
        • Contact:
    • New Jersey
      • Lafayette, New Jersey, United States, 07871
        • Recruiting
        • Performance Rehabilitation
        • Contact:
          • Damon Daura
          • Phone Number: 973-688-4981
      • Totowa, New Jersey, United States, 07871
        • Recruiting
        • Performance Rehabilitation
        • Contact:
          • Damon Daura
          • Phone Number: 973-688-4981
    • Ohio
      • Youngstown, Ohio, United States, 44555
        • Recruiting
        • Youngstown State University
        • Contact:
        • Principal Investigator:
          • Ken E Learman, PhD
    • Oregon
      • Corvallis, Oregon, United States, 97330
        • Recruiting
        • The Corvallis Clinic
        • Contact:
          • Michael Gray
          • Phone Number: 541-754-1265
        • Sub-Investigator:
          • Gary Gray
    • Pennsylvania
      • Havertown, Pennsylvania, United States, 19083
        • Recruiting
        • Pain Relief and Physical Therapy
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

community sample including community members seen in physical therapy clinics where data collection will occur.

Description

Inclusion criteria for the headache attributed to rhinosinusitis (HAR) group:

  • HAR has been present for at least 12 weeks OR
  • Participant has had at least 4 HAR over the past 12 months without persistent symptoms between (chronic or recurrent)
  • Diagnosis of headache attributed to rhinosinusitis (or sinus headaches) according to International Classification of Headache Disorders (ICHD-3)

Exclusion criteria for the HAR group:

  • History of surgery to the cervical spine
  • Whiplash injury within the past 5 years or any persistent symptoms attributable to a whiplash associated disorder
  • Diagnosis of any headache type other than sinus headache with exception of an occasional, mild headache for which they have not sought medical care.

Exclusion criteria for the non-headache group (NHA):

  • Any history of headaches for which they have sought medical care

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Headache Attributed to Rhinosinusitis Group (HAR)
No interventions will be provided.
No intervention will be administered. We are only performing tests and measures.
Headache-Free Control Group (Control)
No interventions will be provided.
No intervention will be administered. We are only performing tests and measures.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
range of motion
Time Frame: Day 1
measured with a cervical range of motion device (CROM)
Day 1

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain Level
Time Frame: Day 1
visual analogue scale
Day 1
disability
Time Frame: Day 1
Neck Disability Index (self-report questionnaire)
Day 1
headache impact
Time Frame: Day 1
Headache Impact Test (self-report questionnaire)
Day 1
sino-nasal outcome test (SNOT-22)
Time Frame: Day 1
self-report questionnaire
Day 1
Cervical side bend rotation test
Time Frame: Day 1
neck range of motion side bending first, then rotating the head and neck
Day 1
cervical flexion rotation test
Time Frame: Day 1
neck range of motion flexing first, then rotating
Day 1
segmental joint mobility
Time Frame: Day 1
manual segmental joint examination
Day 1
neck flexor endurance
Time Frame: Day 1
neck flexor muscle endurance test in supine
Day 1
Beighton score
Time Frame: Day 1
a series of range of motion tests to measure hyper-laxity of joints
Day 1

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Shannon Petersen, PT, Des Moines University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2020

Primary Completion (Anticipated)

December 1, 2022

Study Completion (Anticipated)

December 1, 2022

Study Registration Dates

First Submitted

January 6, 2020

First Submitted That Met QC Criteria

January 7, 2020

First Posted (Actual)

January 9, 2020

Study Record Updates

Last Update Posted (Actual)

September 18, 2020

Last Update Submitted That Met QC Criteria

September 17, 2020

Last Verified

September 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Headache

Clinical Trials on No intervention will be administered. We are only performing tests and measures.

Subscribe